Lymphogranuloma Venereum (LGV): Stages, Symptoms, Diagnosis & Treatment
LGV: An Invasive Chlamydial Infection
Lymphogranuloma venereum (LGV) is caused by Chlamydia trachomatis serovars L1, L2, L3 (distinct from genital serovars D-K). It invades lymphatic tissue, causing progressive disease if untreated. Rising globally, especially among MSM (men who have sex with men).
Three Clinical Stages
Stage 1: Primary (Inoculation) – 3–30 Days Post-Exposure
- Small, painless ulcer/papule at entry site (penis, vulva, vagina, cervix, rectum, pharynx).
- Often unnoticed; heals spontaneously in days.
- May have inguinal lymphadenopathy (rare at this stage).
Stage 2: Secondary (Invasive) – 2–6 Weeks After Primary Lesion
- Buboes: Fluctuant, matted inguinal/femoral lymph nodes; may suppurate, form fistulas/sinuses.
- Groin syndrome: Unilateral (classic) or bilateral; "groove sign" (separation by inguinal ligament).
- Systemic: Fever, chills, malaise, myalgia, arthralgia.
- Anorectal syndrome (if rectal exposure): Tenasmus, rectal pain, discharge, bleeding, constipation.
- Genital ulcers, edema, phimosis (men), vulvar edema (women).
Stage 3: Tertiary (Chronic / Late) – Months to Years
- Fibrosis, strictures: Rectal/anal stenosis, urethral stricture, vaginal stenosis.
- Lymphatic obstruction: Elephantiasis of genitals (esthiomene), lymphedema.
- Chronic fistulas, sinus tracts.
- Infertility (tubal factor).
Diagnosis
- NAAT (PCR) for C. trachomatis from lesion swab, bubo aspirate, rectal/pharyngeal swab, urine.
- LGV-specific PCR (targeting pmpH gene) or genotyping to differentiate from non-LGV chlamydia.
- Serology (complement fixation, microimmunofluorescence) – supportive, not definitive.
- Exclude syphilis (RPR/VDRL + confirmatory), HSV, chancroid, donovanosis, TB, Crohn's.
Treatment (CDC/WHO Guidelines)
| Regimen | Dose & Duration | Notes |
|---|---|---|
| Doxycycline (1st line) | 100 mg PO BID × 21 days | Preferred; treats buboes & systemic. Contraindicated in pregnancy. |
| Erythromycin base | 500 mg PO QID × 21 days | Alternative for pregnancy; GI side effects common. |
| Azithromycin | 1 g PO weekly × 3 weeks | Alternative; less data for LGV. |
- Bubo aspiration: Needle aspiration (not incision) for fluctuant nodes – repeat as needed. Incision & drainage → chronic sinus.
- Partner notification & treatment: All contacts last 60 days (or last partner).
- HIV/STI screening: High co-infection rates (HIV, syphilis, gonorrhea).
- Follow-up: Clinical resolution of buboes (weeks–months); repeat NAAT at 3–4 weeks if symptomatic.
Prevention
- Condom use (reduces but doesn't eliminate risk—skin-to-skin transmission).
- Regular STI screening (q3–6 mo for high-risk).
- Prompt treatment of genital ulcers.
LGV is curable with prolonged antibiotics. Delayed treatment → irreversible structural damage. High index of suspicion in MSM with proctitis or inguinal buboes.
Lymphoma - Related Articles
- Lymphedema and the Circulatory System: Understanding the Connection
- Swollen Lymph Nodes: When to Worry About Cancer vs. Benign Causes
- Understanding Lymph Node Cancer: Symptoms, Types & Diagnosis
- Lymph Node Biopsy: Indications, Types, Procedure & Risks
- Lymphoma Diagnosis: What Happens Next After Suspicion?
- B Cell Lymphoma: Understanding Treatment & Cure Rates
- Lymph Node Basics: Filtration, Locations, and When Swelling Signals Illness
